Individualized recombinant human follicle-stimulating hormone dosing using the CONSORT calculator in assisted reproductive technology: a large, multicenter, observational study of routine clinical practice

Reproductive Technology ◽

Multicenter Observational Study ◽

Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment

Patient Preference and Adherence ◽

10.2147/ppa.s58046 ◽

2014 ◽

pp. 813

Author(s):

Peter Illingworth ◽

Robert Lahoud ◽

Frank Quinn ◽

Kendal Chidwick ◽

Claire Wilkinson ◽

...

Keyword(s):

Observational Study ◽

Reproductive Technology ◽

Ease Of Use ◽

Follitropin Alfa ◽

Assisted Reproductive Technology Treatment ◽

Large multicentre, observational study of a new 2:1 formulation of follitropin alfa and lutropin alfa in assisted reproductive technology (ART) in routine clinical practice

10.1016/j.fertnstert.2009.07.210 ◽

2009 ◽

Vol 92 (3) ◽

pp. S54

Author(s):

K. Bühler ◽

O.G.J. Naether

Keyword(s):

Clinical Practice ◽

Observational Study ◽

Reproductive Technology ◽

Follitropin Alfa

Total follicle stimulating hormone dose is negatively correlated with live births in a donor/recipient model with fresh transfer: an analysis of 8,627 cycles from the Society for Assisted Reproductive Technology Registry

10.1016/j.fertnstert.2020.04.027 ◽

2020 ◽

Vol 114 (3) ◽

pp. 545-551 ◽

Cited By ~ 2

Author(s):

Kathryn L. Shaia ◽

Kelly S. Acharya ◽

Benjamin S. Harris ◽

Jeremy M. Weber ◽

Tracy Truong ◽

...

Keyword(s):

Reproductive Technology ◽

Live Births ◽

Fresh Transfer ◽

Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH) versus human menopausal gonadotropin (u-hMG) in assisted reproductive technology (ART): a study based on german real-world data

10.1016/j.fertnstert.2019.07.626 ◽

2019 ◽

Vol 112 (3) ◽

pp. e194

Author(s):

Klaus F. Bühler ◽

Sandra Guedes ◽

Arthur Allignol ◽

Thomas D’Hooghe ◽

Wilma Bilger ◽

...

Keyword(s):

Real World ◽

Reproductive Technology ◽

Human Menopausal Gonadotropin ◽

Real World Data ◽

World Data ◽

Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis

Frontiers in Endocrinology ◽

10.3389/fendo.2017.00264 ◽

2017 ◽

Vol 8 ◽

Cited By ~ 2

Author(s):

Johnny S. Younis

Keyword(s):

Luteinizing Hormone ◽

Personalized Medicine ◽

Chorionic Gonadotropin ◽

Human Chorionic Gonadotropin ◽

Meta Analysis ◽

Reproductive Technology ◽

Human Menopausal Gonadotropin ◽

Recombinant-follicle stimulating hormone is more effective than urinary human menopausal gonadotropin in ovarian hyperstimulation for assisted reproductive technology treatment

Reproductive Medicine and Biology ◽

10.1111/j.1447-0578.2007.00161.x ◽

2007 ◽

Vol 6 (1) ◽

pp. 27-32 ◽

Cited By ~ 6

Author(s):

KOJI NAKAGAWA ◽

SHIREI OHGI ◽

RIEKO KOJIMA ◽

KANA SUGAWARA ◽

TAKASHI HORIKAWA ◽

...

Keyword(s):

Reproductive Technology ◽

Human Menopausal Gonadotropin ◽

Ovarian Hyperstimulation ◽

Assisted Reproductive Technology Treatment ◽

Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol

10.1016/j.fertnstert.2004.03.061 ◽

2004 ◽

Vol 82 (5) ◽

pp. 1323-1329 ◽

Cited By ~ 216

Author(s):

André Hazout ◽

Philippe Bouchard ◽

David B. Seifer ◽

P. Aussage ◽

Anne Marie Junca ◽

...

Keyword(s):

Reproductive Technology ◽

Inhibin B ◽

Müllerian Inhibiting Substance ◽

Antimullerian Hormone ◽

Antimüllerian Hormone ◽

Stimulating Hormone ◽

Mullerian Inhibiting Substance

Micronized progesteron therapy for normalization of menstrual cycle in routine clinical practice: results of the Russian multicenter observational study

Problemy reproduktsii ◽

10.17116/repro20192505160 ◽

2019 ◽

Vol 25 (5) ◽

pp. 60

Author(s):

I. B. Manuhin ◽

E. A. Yurasova ◽

V. M. Kuleshov ◽

L. V. Tkachenko ◽

S. P. Sinchihin ◽

...

Keyword(s):

Clinical Practice ◽

Menstrual Cycle ◽

Observational Study ◽

Multicenter Observational Study

Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-? (Gonal-F�) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology

Journal of Obstetrics and Gynaecology Research ◽

10.1111/j.1447-0756.2007.00529.x ◽

2007 ◽

Vol 33 (3) ◽

pp. 305-315 ◽

Cited By ~ 15

Author(s):

Shin Yong Moon ◽

Young Sik Choi ◽

Seung-Yup Ku ◽

Seok Hyun Kim ◽

Young Min Choi ◽

...

Keyword(s):

Controlled Ovarian Hyperstimulation ◽

Reproductive Technology ◽

Ovarian Hyperstimulation ◽

Efficacy And Safety ◽

A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology

Reproductive Biology and Endocrinology ◽

10.1186/1477-7827-12-6 ◽

2014 ◽

Vol 12 (1) ◽

pp. 6 ◽

Cited By ~ 4

Author(s):

Klaus Bühler ◽

Olaf GJ Naether ◽

Wilma Bilger

Keyword(s):

Clinical Practice ◽

Reproductive Technology ◽

Surveillance Study ◽

Follitropin Alfa ◽

Post Marketing Surveillance ◽

Post Marketing